在BioDeep NovoCell知识数据库中,参考离子总共被划分为4个级别。
  • Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
  • Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
  • Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
  • Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。

Found 21 Reference Ions Near m/z 770.556
NovoCell ID m/z Mass Window Metabolite Ranking Anatomy Context
MSI_000063093 Reliable 770.5656 770.5655 ~ 770.5657
MzDiff: 0.9 ppm
PC(15:0/20:3(5Z,8Z,11Z)) (BioDeep_00000029262)
Formula: C43H80NO8P (769.5621)
2.41 (100%) Mus musculus
[UBERON:0000956] cerebral cortex
MSI_000006566 Reliable 770.5561 770.556 ~ 770.5562
MzDiff: 0.7 ppm
PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (BioDeep_00000018529)
Formula: C46H80NO8P (805.5621)
5.23 (100%) Rattus norvegicus
[UBERON:0004358] caput epididymis
MSI_000011395 Unreliable 770.5592 770.5592 ~ 770.5592
MzDiff: none
PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (BioDeep_00000018529)
Formula: C46H80NO8P (805.5621)
0.56 (100%) Mus musculus
[UBERON:0012378] muscle layer of urinary bladder
MSI_000011401 Unreliable 770.5513 770.5513 ~ 770.5513
MzDiff: none
LacCer(d18:1/12:0) (BioDeep_00000027943)
Formula: C42H79NO13 (805.5551)
0.55 (100%) Mus musculus
[UBERON:0012378] muscle layer of urinary bladder
MSI_000047098 Unreliable 770.5636 770.5636 ~ 770.5636
MzDiff: none
PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (BioDeep_00000018529)
Formula: C46H80NO8P (805.5621)
2.81 (100%) Homo sapiens
[UBERON:0013067] colorectal mucosa
MSI_000047305 Unreliable 770.5565 770.5565 ~ 770.5565
MzDiff: none
LacCer(d18:1/12:0) (BioDeep_00000027943)
Formula: C42H79NO13 (805.5551)
2.41 (100%) Homo sapiens
[UBERON:0013067] colorectal mucosa
MSI_000051735 Unreliable 770.5632 770.5632 ~ 770.5632
MzDiff: none
PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (BioDeep_00000018529)
Formula: C46H80NO8P (805.5621)
2.51 (100%) Homo sapiens
[UBERON:0001052] rectum
MSI_000052429 Unreliable 770.556 770.556 ~ 770.556
MzDiff: none
LacCer(d18:1/12:0) (BioDeep_00000027943)
Formula: C42H79NO13 (805.5551)
2.03 (100%) Homo sapiens
[UBERON:0001052] rectum
MSI_000052544 Unreliable 770.5488 770.5488 ~ 770.5488
MzDiff: none
Not Annotated 1.72 (0%) Homo sapiens
[UBERON:0001052] rectum
MSI_000000083 Unreliable 770.5513 770.5513 ~ 770.5513
MzDiff: none
LacCer(d18:1/12:0) (BioDeep_00000027943)
Formula: C42H79NO13 (805.5551)
2.09 (100%) Mus musculus
[CL:0000066] epithelial cell
MSI_000000091 Unreliable 770.5592 770.5592 ~ 770.5592
MzDiff: none
PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (BioDeep_00000018529)
Formula: C46H80NO8P (805.5621)
2.08 (100%) Mus musculus
[CL:0000066] epithelial cell
MSI_000002470 Unreliable 770.5654 770.5654 ~ 770.5654
MzDiff: none
PC(15:0/20:3(5Z,8Z,11Z)) (BioDeep_00000029262)
Formula: C43H80NO8P (769.5621)
1.06 (100%) Rattus norvegicus
[UBERON:0001950] neocortex
MSI_000003142 Unreliable 770.5654 770.5654 ~ 770.5654
MzDiff: none
PC(15:0/20:3(5Z,8Z,11Z)) (BioDeep_00000029262)
Formula: C43H80NO8P (769.5621)
1.81 (100%) Rattus norvegicus
[UBERON:0002037] cerebellum
MSI_000005289 Unavailable 770.5654 770.5654 ~ 770.5654
MzDiff: none
PC(15:0/20:3(5Z,8Z,11Z)) (BioDeep_00000029262)
Formula: C43H80NO8P (769.5621)
-0.86 (100%) Rattus norvegicus
[UBERON:0002298] brainstem
MSI_000005964 Unavailable 770.5654 770.5654 ~ 770.5654
MzDiff: none
PC(15:0/20:3(5Z,8Z,11Z)) (BioDeep_00000029262)
Formula: C43H80NO8P (769.5621)
-1.11 (100%) Rattus norvegicus
[UBERON:0002435] striatum
MSI_000028319 Unreliable 770.5529 770.5529 ~ 770.5529
MzDiff: none
PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (BioDeep_00000018529)
Formula: C46H80NO8P (805.5621)
1.41 (100%) Macropus giganteus
[UBERON:0001891] midbrain
MSI_000029987 Unavailable 770.5529 770.5529 ~ 770.5529
MzDiff: none
PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (BioDeep_00000018529)
Formula: C46H80NO8P (805.5621)
-0.39 (100%) Macropus giganteus
[UBERON:0002336] corpus callosum
MSI_000030780 Unreliable 770.5529 770.5529 ~ 770.5529
MzDiff: none
PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (BioDeep_00000018529)
Formula: C46H80NO8P (805.5621)
1.01 (100%) Macropus giganteus
[UBERON:0003027] cingulate cortex
MSI_000031084 Unreliable 770.5591 770.5591 ~ 770.5591
MzDiff: none
Not Annotated 2.54 (0%) Macropus giganteus
[UBERON:0006093] precuneus cortex
MSI_000044406 Unavailable 770.5654 770.5654 ~ 770.5654
MzDiff: none
PC(15:0/20:3(5Z,8Z,11Z)) (BioDeep_00000029262)
Formula: C43H80NO8P (769.5621)
-0.15 (100%) Rattus norvegicus
[UBERON:0002264] olfactory bulb
MSI_000058677 Unreliable 770.5656 770.5656 ~ 770.5656
MzDiff: none
PC(15:0/20:3(5Z,8Z,11Z)) (BioDeep_00000029262)
Formula: C43H80NO8P (769.5621)
0.78 (100%) Mus musculus
[UBERON:0001950] neocortex

Found 19 Sample Hits
Metabolite Species Sample
PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 14.2)
Mus musculus (Urinary bladder)
HR2MSI_mouse_urinary_bladder - S096
Resolution: 10μm, 260x134

Description

Mass spectrometry imaging of phospholipids in mouse urinary bladder (imzML dataset)
The spatial distribution of phospholipids in a tissue section of mouse urinary bladder was analyzed by MALDI MS imaging at 10 micrometer pixel size with high mass resolution (using an LTQ Orbitrap mass spectrometer).

R, ö, mpp A, Guenther S, Schober Y, Schulz O, Takats Z, Kummer W, Spengler B, Histology by mass spectrometry: label-free tissue characterization obtained from high-accuracy bioanalytical imaging. Angew Chem Int Ed Engl, 49(22):3834-8(2010)

Fig. S2: Single ion images of compounds shown in Fig. 1A-B : (upper left to lower right) m/z = 743.5482 (unknown), m/z = 741.5307 (SM (16:0), [M+K]+), m/z = 798.5410 (PC (34:1), [M+K]+), m/z = 616.1767 (heme b, M+), m/z = 772.5253 (PC (32:0), [M+K]+).

Stability of determined mass values was in the range of +/- 1 ppm over 22 hours of measurement (Fig. S4), with a standard deviation of 0.56 ppm. Accuracy data were obtained during tissue scanning experiments by monitoring the mass signal at nominal mass 798. The internal lock mass function of the Orbitrap instrument was used for automatic calibration during imaging measurements, using the known matrix-related ion signals at m/z = 137.0233, m/z = 444.0925 and m/z = 716.1246.

PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 10)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito08_43
Resolution: 17μm, 298x106

Description

PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 10.3)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito08_44
Resolution: 17μm, 299x111

Description

PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 9.6)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito08_46
Resolution: 17μm, 298x106

Description

PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 10)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito08_47
Resolution: 17μm, 301x111

Description

PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 9.9)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito08_48
Resolution: 17μm, 294x107

Description

PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 10)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito01_04
Resolution: 17μm, 178x91

Description

PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 9.6)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito01_03
Resolution: 17μm, 159x110

Description

PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 10.5)
Rattus norvegicus (normal)
epik_dhb_head_ito01_05
Resolution: 17μm, 183x105

Description

PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 10.4)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito01_06
Resolution: 17μm, 183x103

Description

PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 10.5)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito03_14
Resolution: 17μm, 205x103

Description

PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 14.3)
Mus musculus (Lung)
image3
Resolution: 40μm, 146x190

Description

Fig. 4 MALDI-MSI data of mouse lung tissue after administration with D9-choline and U13C-DPPC–containing Poractant alfa surfactant (labels administered 12 h prior to tissue collection). Ion images of (A) m/z 796.6856 ([U13C-DPPC+Na]+), (B) m/z 756.5154 [PC32:0+Na]+), and (C) m/z 765.6079 ([D9-PC32:0+Na]+). D: Overlay image of [U13C-PC32:0+Na]+ (red) and [D9-PC32:0+Na]+ (green). Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC.

PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 16.3)
Mus musculus (Lung)
image4
Resolution: 40μm, 162x156

Description

Fig 6c Fig. 6 MALDI-MSI of U13C-PC16:0/16:0 acyl chain remodeling. A: Averaged MALDI mass spectrum from lung tissue collected from mice euthanized 12 h after administration of D9-choline and U13C-DPPC–containing Poractant alfa surfactant. The ion at m/z 828.6321 is assigned as the [M+Na]+ ion of 13C24-PC16:0_20:4 formed by acyl remodeling of U13C-PC16:0/16:0. The “NL” value refers to the intensity of the base peak in the full range MS1 spectrum. B: MS/MS spectrum of precursor ions at m/z 828.5 ± 0.5 with fragment ions originating from [13C24-PC16:0_20:4+Na]+ annotated. Part-per-million (ppm) mass errors are provided in parentheses. C, D: MALDI-MSI data of [U13C-DPPC+Na]+ (blue), [PC36:4+Na]+ (green) and [13C24-PC16:0_20:4+Na]+ (red) in lung tissue collected from mice (C) 12 h and (D) 18 h after label administration. All images were visualized using total-ion-current normalization and hotspot removal (high quantile = 99%). MS/MS, tandem mass spectrometry; MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC.

PC(15:0/20:3(5Z,8Z,11Z))

Formula: C43H80NO8P (769.5621)
Adducts: [M+H]+ (Ppm: 5.3)
Mus musculus (Lung)
image2
Resolution: 40μm, 550x256

Description

Supplementary Figure S6. Ion distribution images for (a) [PC36:4+Na]+ (m/z 804.5514) and (b) [PC38:6+Na]+ (m/z 828.5515) obtained from mouse lung tissue collected 6 h after administration of D9- choline and U13C-DPPC–containing CHF5633. Parts-per-million (ppm) mass errors are indicated in parentheses. (c) Magnification of the boxed region in (a) with selected bronchiolar regions outlined in white boxes. (d) The corresponding H&E-stained tissue section with the same selected bronchiolar regions outlined in black boxes. These data demonstrate the co-localisation of the polyunsaturated lipids PC36:4 and PC38:6 with the bronchiolar regions of the lung. All MSI images were visualised using total ion current normalisation and hotspot removal (high quantile = 99%).

PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 6)
Macropus giganteus (Brain)
170321_kangaroobrain-dan3-pos_maxof50.0_med1
Resolution: 50μm, 81x50

Description

Sample information Organism: Macropus giganteus (kangaroo) Organism part: Brain Condition: Wildtype Sample growth conditions: Wild

PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 19.4)
Mus musculus (Liver)
Salmonella_final_pos_recal
Resolution: 17μm, 691x430

Description

A more complete and holistic view on host–microbe interactions is needed to understand the physiological and cellular barriers that affect the efficacy of drug treatments and allow the discovery and development of new therapeutics. Here, we developed a multimodal imaging approach combining histopathology with mass spectrometry imaging (MSI) and same section imaging mass cytometry (IMC) to study the effects of Salmonella Typhimurium infection in the liver of a mouse model using the S. Typhimurium strains SL3261 and SL1344. This approach enables correlation of tissue morphology and specific cell phenotypes with molecular images of tissue metabolism. IMC revealed a marked increase in immune cell markers and localization in immune aggregates in infected tissues. A correlative computational method (network analysis) was deployed to find metabolic features associated with infection and revealed metabolic clusters of acetyl carnitines, as well as phosphatidylcholine and phosphatidylethanolamine plasmalogen species, which could be associated with pro-inflammatory immune cell types. By developing an IMC marker for the detection of Salmonella LPS, we were further able to identify and characterize those cell types which contained S. Typhimurium. [dataset] Nicole Strittmatter. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging, metabolights_dataset, V1; 2022. https://www.ebi.ac.uk/metabolights/MTBLS2671.

LacCer(d18:1/12:0)

Formula: C42H79NO13 (805.5551)
Adducts: [M+H-2H2O]+ (Ppm: 19.8)
Homo sapiens (colorectal adenocarcinoma)
80TopL, 50TopR, 70BottomL, 60BottomR-profile
Resolution: 17μm, 137x136

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).

PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Formula: C46H80NO8P (805.5621)
Adducts: [M+H-2H2O]+ (Ppm: 10.8)
Homo sapiens (colorectal adenocarcinoma)
520TopL, 490TopR, 510BottomL, 500BottomR-profile
Resolution: 17μm, 147x131

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).

LacCer(d18:1/12:0)

Formula: C42H79NO13 (805.5551)
Adducts: [M+H-2H2O]+ (Ppm: 19.1)
Homo sapiens (colorectal adenocarcinoma)
439TopL, 409TopR, 429BottomL, 419BottomR-profile
Resolution: 17μm, 157x136

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).